{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T18:06:11Z","timestamp":1763661971457,"version":"3.44.0"},"reference-count":21,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,3,9]]},"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:p>A 61-year-old male patient being treated with intravenous antibiotics for left foot osteomyelitis presented to the hospital septic, with several days of worsening abdominal pain, bloating and watery bowel movements. Investigation revealed that the patient had severe, treatment-resistant <jats:italic>Clostridioides difficile<\/jats:italic> colitis. He was initially treated with oral vancomycin and intravenous metronidazole, which was switched to oral fidaxomicin. After no improvement in the patient\u2019s symptoms, he was treated with two faecal microbiota transplants. He was offered a third faecal microbiota transplant but declined. The patient was placed back on oral fidaxomicin and saw ultimate resolution of his symptoms. This case provides an example of a treatment pathway for refractory <jats:italic>C. difficile<\/jats:italic> infection.<\/jats:p>","DOI":"10.1136\/bcr-2019-233095","type":"journal-article","created":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T05:29:23Z","timestamp":1585546163000},"page":"e233095","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Management of difficult-to-treat <i>Clostridioides difficile<\/i> in a patient with chronic osteomyelitis"],"prefix":"10.1136","volume":"13","author":[{"given":"Mikaela Highland","family":"Sullivan","sequence":"first","affiliation":[{"name":"Department of Family Medicine, UNC-Chapel Hill, Chapel Hill, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria Lynn","family":"Boggiano","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, UNC-Chapel Hill, Chapel Hill, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly Lacy","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, UNC-Chapel Hill, Chapel Hill, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,3,29]]},"reference":[{"key":"2025082710175368000_13.3.e233095.1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.18.2.247-263.2005"},{"key":"2025082710175368000_13.3.e233095.2","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1086\/521863","article-title":"Clinical recognition and diagnosis of Clostridium difficile infection","volume":"46(Suppl 1)","author":"Bartlett","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2025082710175368000_13.3.e233095.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2014.06.011"},{"key":"2025082710175368000_13.3.e233095.4","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.09.010407","article-title":"Global burden of Clostridium difficile infections: a systematic review and meta-analysis","volume":"9","author":"Balsells","year":"2019","journal-title":"J Glob Health"},{"key":"2025082710175368000_13.3.e233095.5","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0b013e3283411634"},{"key":"2025082710175368000_13.3.e233095.6","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.1041104"},{"key":"2025082710175368000_13.3.e233095.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2012.01.004"},{"key":"2025082710175368000_13.3.e233095.8","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix1085"},{"key":"2025082710175368000_13.3.e233095.9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/5584_2018_322","article-title":"Clostridium difficile colitis prevention and treatment","volume":"1125","author":"Dinleyici","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"2025082710175368000_13.3.e233095.10","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-019-03539-6"},{"key":"2025082710175368000_13.3.e233095.11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4609"},{"key":"2025082710175368000_13.3.e233095.12","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.01242","article-title":"Mechanistic insights in the success of fecal microbiota transplants for the treatment of Clostridium difficile Infections","volume":"9","author":"Baktash","year":"2018","journal-title":"Front Microbiol"},{"key":"2025082710175368000_13.3.e233095.13","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8414257","article-title":"Clostridium difficile Infections: A Global Overview of Drug Sensitivity and Resistance Mechanisms","volume":"2018","author":"Banawas","year":"2018","journal-title":"Biomed Res Int"},{"key":"2025082710175368000_13.3.e233095.14","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70374-7"},{"key":"2025082710175368000_13.3.e233095.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0910812"},{"key":"2025082710175368000_13.3.e233095.16","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1093\/cid\/cis462","article-title":"Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin","volume":"55 (Suppl 2)","author":"Cornely","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2025082710175368000_13.3.e233095.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1205037"},{"key":"2025082710175368000_13.3.e233095.18","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14201"},{"key":"2025082710175368000_13.3.e233095.19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210016","article-title":"Fecal microbiota transplantation for treatment of recurrent C. difficile infection: an updated randomized controlled trial meta-analysis","volume":"14","author":"Hui","year":"2019","journal-title":"PLoS One"},{"key":"2025082710175368000_13.3.e233095.20","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000410"},{"key":"2025082710175368000_13.3.e233095.21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/nyas.13958","article-title":"Novel therapies and preventative strategies for primary and recurrent Clostridium difficile infections","volume":"1435","author":"Dieterle","year":"2019","journal-title":"Ann N Y Acad Sci"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2019-233095","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T17:18:01Z","timestamp":1756315081000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2019-233095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":21,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3,29]]},"published-print":{"date-parts":[[2020,3]]}},"alternative-id":["10.1136\/bcr-2019-233095"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2019-233095","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2020,3]]}}}